BMS at Digestive Disease Week® (DDW) Virtual Meeting

Highlighting innovative research and commitment to patients in gastroenterology

Intended for U.S. scientific audiences only.
T

he Digestive Disease Week® (DDW) Virtual Meeting is an important opportunity for scientific exchange on the latest advances in gastrointestinal (GI) research, medicine and technology. We look forward to showcasing data that demonstrate our commitment to research for people living with GI immune-mediated diseases.

Our Data at Digestive Disease Week

Read more about our key data being presented at the meeting.

Our data at DDW 2021

At Digestive Disease Week, Bristol Myers Squibb is presenting data from multiple studies evaluating Zeposia (ozanimod), which is being investigated in ulcerative colitis.

Our Science   

We are pursuing pathbreaking science and innovative solutions to potentially improve outcomes in GI immune-mediated diseases. Read how our scientists are addressing some of the most challenging diseases of our time, particularly in gastroenterology.

Mark Osterman, VP, Gastroenterology Disease Area Head
Inflammatory bowel disease (IBD): research, partnerships and Bristol Myers Squibb’s dedication to patients – A Q&A with Mark Osterman >

Hear how experience as a physician is shaping the approach Mark Osterman, M.D, disease area head, Gastroenterology is applying to IBD research.

Shining a light on inflammatory bowel disease (IBD)
Break the silence: shining a light on inflammatory bowel disease (IBD) >

Learn more from the European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA) on how “breaking the silence” during this year’s World IBD Day can make a lasting impact on IBD patients in need. 

Mary Beth Harler, M.D.
Advancing gastroenterology research for patients: a Q&A with Mary Beth Harler >

Mary Beth Harler, M.D., senior vice president and head of Immunology & Fibrosis Development, describes how Bristol Myers Squibb is committed to advancing innovative science in gastroenterology.

Understanding the needs of people living with inflammatory bowel disease (IBD)
Understanding the needs of people living with inflammatory bowel disease (IBD) >

Learn how Bristol Myers Squibb is committed to ongoing research in inflammatory bowel disease.

Resources

Learn more about our research in IBD through the resources below.

TYK2 Pathway Fact Sheet
TYK2 Pathway Fact Sheet >

Learn about the scientific mechanism behind the TYK2 pathway and its role in immune-mediated diseases.

Immunology Pathways

Immunology Pathways is a resource for U.S. healthcare professionals with information on immune-mediated diseases like IBD, including signs and symptoms and disease and clinical trial tools, emerging pathways involved in the pathogenesis of disease and videos and dynamic resources.

Ulcerative Colitis Infographic
Ulcerative Colitis Infographic >

Learn more about ulcerative colitis, its symptoms and effects on patients. 

Crohn's Disease Infographic
Crohn's Disease Infographic >

Learn more about Crohn’s disease, a gastroenterological condition that affects patients worldwide.